Skip to content
Screener

Price / sales at other companies

Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
21.8×+9.6×
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
89.8×+21.2×
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
+2.8×
Cytokinetics logo
CytokineticsCYTK
170.9×+124×
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
22.4×-24.9×
BridgeBio Pharma logo
BridgeBio PharmaBBIO
24.8×-26.8×

Other financials

Income statement

See full
Revenue$243.6M+55.4%
Gross profit$220.0M+59.2%
Operating income$27.2M+34.9%
Net income$25.4M+42.6%
EPS (diluted)$0.30+30.4%

Balance sheet

See full
Cash & equivalents$175.7M-8.5%
Total debt$8.9M-8.9%
Total equity$654.1M+32.1%
Total assets$896.1M+35.5%

Cash flow

See full
Operating cash flow$47.2M+68.0%
CapEx$663.0K+302%
Free cash flow$46.5M+66.6%

Valuation

See full
Market cap$5.97B+146%
Enterprise value$5.8B+159%
P/E74×-432×

Profitability

See full
Gross margin89.8%+3.9pp
Operating margin11.9%+11.1pp
Net margin9.6%+8.7pp
FCF margin21.7%+8.8pp

Returns & leverage

See full
Return on equity14%+13.0pp
Debt / equity0.0×
Current ratio3.9×+0.3×

Where this comes from

Calculated from Kiniksa Pharmaceuticals International, plc’s reported figures.

Based on the most recent quarter.

The source filing: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed July 28, 2026. Open the filing →

Filed
Jul 28, 2026, 4:17 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001104659-26-087545

FAQ

What is Kiniksa Pharmaceuticals International, plc's price / sales?
Kiniksa Pharmaceuticals International, plc (KNSA) reported price / sales of 5.9× in Q2 2026.
How has Kiniksa Pharmaceuticals International, plc's price / sales changed year-over-year?
Kiniksa Pharmaceuticals International, plc's price / sales increased by 46.1% year-over-year, from 4× to 5.9×.
What is the long-term trend for Kiniksa Pharmaceuticals International, plc's price / sales?
Over 4 years (2021 to 2025), Kiniksa Pharmaceuticals International, plc's price / sales has grown at a -31.6% compound annual growth rate (CAGR), from 21× to 4.6×.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.

Ask your AI about Kiniksa Pharmaceuticals International, plc's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude